Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,042	1,376	719	486	511	553
Market Cap Growth	29.52%	91.51%	47.79%	-4.80%	-7.70%	-
Enterprise Value	1,889	1,378	535	299	380	429
Last Close Price	25.12	29.52	19.50	15.95	17.46	24.52
PE Ratio	-	-7.38	-4.85	-5.76	-4.27	-5.36
PS Ratio	8.41	7.38	9.32	25.40	-	-
PB Ratio	8.03	5.53	5.06	4.04	2.97	4.25
P/FCF Ratio	-31.88	-19.37	-5.97	-3.66	-5.72	-13.96
P/OCF Ratio	-31.95	-19.40	-5.98	-3.66	-5.73	-14.06
EV/Sales Ratio	8.43	7.39	6.95	15.62	-	-
EV/EBITDA Ratio	-12.89	-14.01	-4.18	-1.73	-3.66	-7.85
EV/EBIT Ratio	-11.09	-12.62	-4.08	-1.72	-3.65	-7.83
EV/FCF Ratio	-32.47	-19.39	-4.45	-2.25	-4.26	-10.81
Debt / Equity Ratio	1.31	1.24	0.02	0.02	0.02	0.03
Debt / FCF Ratio	-8.30	-4.34	-0.02	-0.02	-0.04	-0.09
Asset Turnover	0.45	0.37	0.24	0.07	-	-
Inventory Turnover	4.24	3.37	3.50	-	-	-
Quick Ratio	3.38	4.07	2.71	3.76	12.56	8.92
Current Ratio	3.68	4.45	2.94	3.91	12.80	9.13
Return on Equity (ROE)	-84.40%	-83.65%	-103.46%	-57.47%	-68.29%	-60.80%
Return on Assets (ROA)	-13.76%	-13.65%	-25.33%	-40.48%	-33.64%	-34.44%
Return on Capital (ROIC)	-19.79%	-19.46%	-61.42%	-72.70%	-42.14%	-38.76%
Earnings Yield	-8.41%	-11.88%	-18.88%	-17.27%	-20.22%	-9.50%
FCF Yield	-1.17%	-5.16%	-16.76%	-27.31%	-17.49%	-7.16%
Buyback Yield / Dilution	-24.56%	-20.31%	-12.07%	-20.08%	-119.84%	-1177.21%
Total Shareholder Return	-24.56%	-20.31%	-12.07%	-20.08%	-119.84%	-1177.21%

Source: S&P Capital IQ. Standard template.